Invention Grant
- Patent Title: Heparin conjugated to collagen-binding peptides for targeting to biological and synthetic tissues
-
Application No.: US16755494Application Date: 2018-10-11
-
Publication No.: US12036234B2Publication Date: 2024-07-16
- Inventor: Guillermo A. Ameer , Jason A. Wertheim , Bin Jiang , Kyle Koss
- Applicant: Northwestern University
- Applicant Address: US IL Evanston
- Assignee: Northwestern University
- Current Assignee: Northwestern University
- Current Assignee Address: US IL Evanston
- Agency: Quarles & Brady LLP
- International Application: PCT/US2018/055434 2018.10.11
- International Announcement: WO2019/075213A 2019.04.18
- Date entered country: 2020-04-10
- Main IPC: A61K31/727
- IPC: A61K31/727 ; A61K38/08 ; A61K47/54 ; A61K47/64

Abstract:
Disclosed are heparin conjugates comprising heparin conjugated to a peptide that binds to a protein of the extracellular matrix (ECM) of cellular tissue, such as a collagen-binding peptide that binds to collagen of the ECM. The disclosed heparin conjugates may be utilized in methods that include treating ECM material to incorporate the heparin conjugates and impart anticoagulant activity to the ECM. The disclosed heparin conjugates also may be formulated as pharmaceutical compositions for treating and/or preventing vascular injuries and conditions.
Public/Granted literature
- US20210299158A1 Heparin Conjugated to Collagen-Binding Peptides for Targeting to Biological and Synthetic Tissues Public/Granted day:2021-09-30
Information query
IPC分类: